If I were Nasrat and don’t have an ideal acquisition offer, then I would reach out to all big pharma companies and offer to manufacture their multi-billion dollar, block-buster drugs in the U.S. for an ideal fee.
Unlimited partnerships with unlimited block-buster, billion dollar drugs to manufacture.
Run the manufacturing plant 24/7 and expand, expand, and expand.Perhaps even selling some of our low market potential drugs to dedicate more time to manufacture the multi-billion drugs.
All big pharma companies that partners up with Elite will win big by avoiding the tariff with drugs manufactured in the U.S.
Elite wins big with every contract/agreement signed and with every multi billion dollars drugs manufactured by Elite.
Press release after press release after press release after every agreement signed will drive the price per share parabolically.
As these press releases come come, more and more big pharma companies will seek help from Elite to help them solve their tariff dilemma.
Where am I wrong?
Is this what Narsat is thinking of and might be in the midst of negotiations of such agreements right now.
He leaves us with a lot of clues/hints with every conference call.
Let me know what you folks think of this growth strategy.
I dream of $7+ eventually after all these contracts/agreements are signed.
Peek at Amneal (AMRX) as an indicator of what Elite can become especially with net profit and EPS much better than Amneal soon.
Bullish
Market Data 
Markets 
AI
